title: Robotic liver donor right hepatectomy: A pure, minimally invasive approach.
abstract: Right hepatectomy for a living liver donor via a pure minimally invasive approach is a challenging procedure and only a few cases have been reported. Between May 2013 and August 2015, 13 patients underwent robotic living donor right hepatectomy in our institute, and 54 patients received open surgery. In this series, no conversion was conducted for robotic donor right hepatectomy. The 2 groups shared similar blood loss (169 versus 146 mL), complication rates (7.7% versus 9.3%), and recovery of donor liver function (peak alanine aminotransferase, 269 versus 252 IU/mL). The robotic group needed longer operation time (596 versus 383 minutes) but less postoperative patient-controlled analgesia (0.58 versus 0.84 ng/kg) and a shorter period before returning to work/school (52.9 versus 100.0 days) and sex (100.0 versus 156.0 days). For recipient outcomes regarding the donor procedure, the robotic group shared similar experiences in early allograft dysfunction, complications, and 1-year recipient liver function with the open group. With respect to documented benefits of minimally invasive left-sided liver donor procedure, the development of right donor hepatectomy is slow. In conclusion, with substantial improvements in patient recovery after the minimally invasive approach, the robotic platform would be a big step toward completing pure minimally invasive liver donor surgery. Liver Transplantation 22 1509-1518 2016 AASLD.
authors: Department of Surgery, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan.
authors: Po-Da
authors: PD
authors: Chen
authors: Department of Surgery, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan.
authors: Chao-Ying
authors: CY
authors: Wu
authors: Department of Surgery, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan.
authors: Rey-Heng
authors: RH
authors: Hu
authors: Department of Surgery, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan.
authors: Cheng-Maw
authors: 0000-0003-1874-7615
authors: CM
authors: Ho
authors: Department of Surgery, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan.
authors: Po-Huang
authors: PH
authors: Lee
authors: Department of Surgery, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan.
authors: Hong-Shiee
authors: HS
authors: Lai
authors: Department of Surgery, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan.
authors: Ming-Tsan
authors: MT
authors: Lin
authors: Department of Surgery, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan. wyaoming@gmail.com.
authors: Yao-Ming
authors: YM
authors: Wu
mesh_terms: D000410:Alanine Transaminase / Q000097:blood; D016058:Analgesia, Patient-Controlled; D001219:Aspartate Aminotransferases / Q000097:blood; D016063:Blood Loss, Surgical; D005240:Feasibility Studies; D005260:Female; D006498:Hepatectomy / Q000009:adverse effects / Q000379:methods*; D006801:Humans; D010535:Laparoscopy; D007902:Length of Stay; D008099:Liver / Q000601:surgery; D008111:Liver Function Tests; D016031:Liver Transplantation / Q000379:methods*; D019520:Living Donors; D008297:Male; D019060:Minimally Invasive Surgical Procedures / Q000009:adverse effects / Q000379:methods*; D061646:Operative Time; D011183:Postoperative Complications / Q000453:epidemiology; D012189:Retrospective Studies; D065287:Robotic Surgical Procedures / Q000009:adverse effects / Q000379:methods*; D013997:Time Factors; D020858:Tissue and Organ Harvesting / Q000009:adverse effects / Q000379:methods*
chemical_list: D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase